Physician

Muhammad Sarfraz Nawaz, MD

According to 2025 Medicare claims, Muhammad Nawaz, MD (NPI: 1619222544) practices internal medicine in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Marion, IN. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 46260-2082. Nawaz is affiliated with the Ascension Care Management (ACO ID: A2600), IRCCO (ACO ID: A2619), CHSPSC ACO 2, LLC (ACO ID: A3664), Caravan Collaborative Pathways (ACO ID: A4604), WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Nawaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 669 traditional Medicare patients, billed 121,608 HCPCS/CPT codes, and received $2,595,663 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,774 prescription claims across 278 beneficiaries totaling $4,075,349 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 35 claims. Open Payments data shows 181 records totaling $62,085. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $18,163 to $2,595,663. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,584 to $4,075,349. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $18,163 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $49,016 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $20,154 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,862 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,524 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $92,269 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,503,871 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,422,689 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,692,437 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,595,663 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201574214$18,163
2016200575$49,016
2017119264$20,154
20181836$2,862
20192950$3,524
20201856,542$92,269
2021638103,576$1,503,871
2022667150,970$2,422,689
2023701194,832$2,692,437
2024669121,608$2,595,663

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$4.1M2015 Drug cost: $5,584 (USD; Tot_Drug_Cst)2016 Drug cost: $8,321 (USD; Tot_Drug_Cst)2017 Drug cost: $15,585 (USD; Tot_Drug_Cst)2018 Drug cost: $29,773 (USD; Tot_Drug_Cst)2019 Drug cost: $123,908 (USD; Tot_Drug_Cst)2020 Drug cost: $133,248 (USD; Tot_Drug_Cst)2021 Drug cost: $2,160,442 (USD; Tot_Drug_Cst)2022 Drug cost: $3,298,498 (USD; Tot_Drug_Cst)2023 Drug cost: $2,866,214 (USD; Tot_Drug_Cst)2024 Drug cost: $4,075,349 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152091$5,584
201644168$8,321
201748105$15,585
20183275$29,773
201954195$123,908
202043130$133,248
20212291,127$2,160,442
20222501,315$3,298,498
20232711,663$2,866,214
20242781,774$4,075,349

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$956$1.9K2023 Medicare payment: $1,913 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R35$1,913
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4071,058$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more209318$56
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's113195$12
36415Insertion of needle into vein for collection of blood sample3111,021$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count256802$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib461,288$717,701
ImbruvicaIbrutinib471,324$648,472
RevlimidLenalidomide25616$417,795
JakafiRuxolitinib Phosphate21630$403,573
BrukinsaZanubrutinib25750$308,008

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.181$62,085Pharmacosmos Therapeutics Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

Explore More Providers

FAQ

What Medicare data is available for Muhammad Sarfraz Nawaz, MD?

Tedicare shows public-source Medicare data for Muhammad Sarfraz Nawaz, MD (NPI 1619222544), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Sarfraz Nawaz, MD have ACO affiliation data?

Muhammad Sarfraz Nawaz, MD is shown with ACO affiliation data for Ascension Care Management (MSSP, ACO ID A2600), IRCCO (MSSP, ACO ID A2619), CHSPSC ACO 2, LLC (MSSP, ACO ID A3664), Caravan Collaborative Pathways (MSSP, ACO ID A4604), WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Muhammad Sarfraz Nawaz, MD?

Muhammad Sarfraz Nawaz, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Muhammad Sarfraz Nawaz, MD have Open Payments data?

Muhammad Sarfraz Nawaz, MD has 181 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.